Polyacrylic Acid (CAS 9003-01-4) Market Size, Share, Growth, and Industry Analysis, By Type (PAA Carbomer 940, PAA Carbomer 980, PAA Carbomer 676, PAA Carbomer U20, PAA Carbomer U21, PAA Carbomer SF-1), By Application (Personal Care and Cosmetics, Pharmaceutical), Regional Insights and Forecast to 2035

Polyacrylic Acid (CAS 9003014) Market Overview

Global Polyacrylic Acid (CAS 9003-01-4) Market size is projected to reach USD 2081.88 Million by 2035, rising from USD 1083.49 Million in 2026 at a CAGR of 7.53%.

The Polyacrylic Acid (CAS 9003014) market is expanding steadily due to strong consumption across personal care, pharmaceuticals, water treatment, and industrial formulations. More than 42% of global demand originates from cosmetic and personal care applications, while pharmaceutical usage contributes nearly 28% of total consumption. Polyacrylic acid production exceeded 1.9 million metric tons in 2025, supported by rising manufacturing activity in AsiaPacific and North America. More than 310 manufacturers currently operate across 27 countries, with China accounting for 36% of global production capacity. Highperformance carbomer grades such as Carbomer 940 and Carbomer 980 collectively represent 48% of commercial demand due to superior rheology and thickening performance.

The United States accounts for nearly 24% of global polyacrylic acid consumption due to high demand from cosmetics, skincare, oral care, and pharmaceutical sectors. More than 4,300 cosmetic product manufacturers in the U.S. use carbomerbased formulations in gels, creams, and lotions. Approximately 61% of dermatological creams sold in the country contain acrylic polymer stabilizers. Pharmaceuticalgrade polyacrylic acid demand increased by 11% during 2025 due to rising topical drug applications and controlledrelease formulations. The U.S. imported over 148,000 metric tons of acrylic acid derivatives in 2025, while domestic production facilities operated at an average utilization rate of 82% across major chemical manufacturing hubs.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: More than 68% of skincare and topical pharmaceutical formulations depend on acrylicbased rheology modifiers, while 54% of industrial manufacturers increased polymer additive consumption to improve viscosity stabilization and suspension efficiency.

• Major Market Restraint: Nearly 39% of manufacturers reported raw material price instability, while 33% of production facilities experienced supply chain disruptions linked to acrylic acid procurement and energyintensive polymer processing operations.

• Emerging Trends: Around 47% of new cosmetic product launches now contain carbomerbased ingredients, while biocompatible polymer adoption increased by 29% due to demand for sustainable and lowirritation formulations.

• Regional Leadership: AsiaPacific controls approximately 44% of total market volume, supported by 52% of global cosmetics manufacturing output and 48% of pharmaceutical intermediate production capacity concentrated in the region.

• Competitive Landscape: The top five manufacturers collectively account for nearly 58% of global production capacity, while integrated chemical companies maintain over 63% control in pharmaceuticalgrade polyacrylic acid distribution networks.

• Market Segmentation: Carbomer 940 and Carbomer 980 together contribute nearly 48% of product demand, while personal care and cosmetics applications represent approximately 57% of overall consumption volume globally.

• Recent Development: During 2025, more than 31% of manufacturers invested in automated polymerization technologies, while 26% expanded pharmaceuticalgrade production facilities to support increasing topical drug formulation demand.

Polyacrylic Acid (CAS 9003014) Market Latest Trends

The Polyacrylic Acid (CAS 9003014) market is witnessing strong technological transformation driven by demand from personal care and pharmaceutical industries. More than 62% of premium skincare products launched in 2025 incorporated carbomerbased rheology modifiers due to enhanced texture stability and longer shelf life. Demand for highpurity carbomer grades increased by 17% because of strict pharmaceutical formulation requirements. Manufacturers in China, India, Germany, and the United States collectively expanded production capacity by over 210,000 metric tons during 2024 and 2025.

Sustainable manufacturing has emerged as a major trend, with approximately 34% of producers implementing lowemission polymerization systems. Waterbased formulations now account for nearly 58% of global acrylic polymer applications, reflecting increased environmental compliance across cosmetic manufacturing. Digital quality monitoring systems were adopted by 41% of leading production facilities to reduce contamination rates and improve viscosity precision.

How is technological advancement driving the Polyacrylic Acid (CAS 9003-01-4) Market?

Technological advancement is playing a vital role in accelerating the Polyacrylic Acid (CAS 9003-01-4) Market by improving polymer manufacturing efficiency, product purity, formulation performance, and environmental sustainability. Manufacturers are increasingly investing in automated polymerization technologies, AI-enabled quality monitoring systems, advanced purification processes, and low-emission manufacturing methods to produce pharmaceutical-grade and cosmetic-grade carbomers with greater consistency. During 2025, more than 31% of manufacturers invested in automated polymerization technologies, while approximately 41% of leading production facilities adopted digital quality monitoring systems to improve viscosity precision and reduce contamination. Around 34% of producers implemented low-emission polymerization systems, and 46% of solvent and polymer suppliers developed recyclable processing technologies to support sustainable manufacturing. Continuous innovation has also resulted in advanced transparent gel polymers with improved electrolyte tolerance, faster dispersion characteristics, enhanced rheology control, and lower residual solvent content, making them suitable for premium skincare products, topical pharmaceuticals, and controlled-release drug formulations. These technological developments are enabling manufacturers to improve production efficiency, comply with stricter regulatory standards, and meet the growing demand for high-performance acrylic polymers across pharmaceutical, cosmetic, and industrial applications.

Polyacrylic Acid (CAS 9003014) Market Dynamics

The Polyacrylic Acid (CAS 9003014) market is influenced by expanding pharmaceutical manufacturing, rising cosmetic production, increasing industrial water treatment demand, and technological innovation in polymer processing. More than 71 countries currently import acrylic polymer materials for industrial and healthcare applications. Approximately 58% of manufacturers prioritize pharmaceuticalgrade production expansion, while 43% focus on sustainable and lowemission polymerization systems.

DRIVER

Rising demand for pharmaceuticals and personal care products.

The growing expansion of the pharmaceutical and personal care industries continues to be the primary growth driver for the Polyacrylic Acid (CAS 9003014) Market as manufacturers increasingly utilize carbomer-based polymers for viscosity modification, suspension stabilization, controlled drug delivery, and formulation enhancement. Approximately 61% of skincare creams, gels, lotions, and cosmetic formulations worldwide utilize carbomer stabilizers because of their excellent thickening efficiency, transparency, rheological control, and compatibility with a wide range of active ingredients. Rising production of topical pharmaceuticals, dermatological preparations, wound care products, oral care formulations, and premium cosmetic products continues driving demand for high-purity polyacrylic acid grades across global healthcare and beauty industries. Increasing consumer preference for high-performance personal care products, coupled with continuous pharmaceutical innovation, encourages manufacturers to expand production of pharmaceutical-grade acrylic polymers capable of meeting stringent quality and performance requirements.

Manufacturers continue investing in advanced polymerization technologies, improved purification systems, and specialty carbomer formulations that deliver enhanced stability, superior texture, controlled release performance, and improved product shelf life. Expansion of dermatology treatments, cosmetic innovation, anti-aging skincare products, and pharmaceutical research continues creating sustained opportunities for polyacrylic acid suppliers serving global healthcare and beauty markets. Continuous development of multifunctional polymer excipients and increasing demand for premium formulations are expected to support long-term market growth.

RESTRAINT

Volatility in acrylic acid raw material supply.

The Polyacrylic Acid (CAS 9003014) Market continues facing restraints due to fluctuations in acrylic acid availability, petrochemical feedstock pricing, and supply chain disruptions that directly influence manufacturing costs and production stability. Approximately 19% fluctuation in acrylic acid prices during 2025 created uncertainty for polymer manufacturers as changes in crude oil prices, feedstock shortages, transportation disruptions, and energy-intensive production processes increased procurement costs throughout the supply chain. Manufacturers are required to carefully manage raw material inventories while maintaining consistent production quality, making long-term operational planning increasingly challenging during periods of market volatility.

Additional pressure comes from rising environmental compliance costs, wastewater treatment requirements, emission reduction investments, and stricter industrial regulations governing chemical manufacturing operations. Supply chain interruptions, temporary production shutdowns, international logistics constraints, and fluctuating transportation expenses continue affecting manufacturing efficiency and product availability across global markets. These factors remain significant barriers for manufacturers seeking stable production while maintaining competitive pricing and consistent customer supply.

OPPORTUNITY

Expansion of highpurity pharmaceuticalgrade carbomers.

The rapid growth of pharmaceutical manufacturing, advanced drug delivery systems, and high-value healthcare formulations presents significant opportunities for the Polyacrylic Acid (CAS 9003014) Market as pharmaceutical companies increasingly require highly purified carbomer materials. Approximately 16% growth in pharmaceutical-grade carbomer demand during 2025 reflects expanding utilization in topical medications, controlled-release formulations, oral care products, ophthalmic preparations, and dermatological therapies requiring exceptional purity, stability, and formulation performance. Growing investment in pharmaceutical production facilities, biotechnology research, and advanced formulation development continues strengthening demand for specialized acrylic polymer excipients capable of supporting complex pharmaceutical manufacturing processes.

Manufacturers are expanding production capacity, improving purification technologies, and developing innovative polymer grades specifically designed for highly regulated pharmaceutical applications. Increasing launches of dermatological products, expanding biologics manufacturing, and continuous investment in pharmaceutical infrastructure across emerging healthcare markets continue creating favorable opportunities for suppliers of pharmaceutical-grade polyacrylic acid. Ongoing advances in drug formulation technologies and personalized medicine are expected to further strengthen future market demand.

CHALLENGE

Environmental regulations and waste management compliance.

Environmental regulations continue presenting significant challenges for the Polyacrylic Acid (CAS 9003014) Market because polymer manufacturing involves chemical processing, wastewater generation, energy consumption, and emission control requirements that require continuous operational improvements. Approximately 31% of production facilities upgraded wastewater treatment systems during 2025 to comply with stricter environmental standards governing industrial discharge, chemical waste management, and sustainable manufacturing practices. Compliance with increasingly demanding environmental legislation requires substantial investment in treatment infrastructure, emission monitoring systems, recycling technologies, and environmentally responsible production methods.

Manufacturers must also address rising regulatory expectations regarding carbon emissions, resource efficiency, chemical handling, and waste disposal while maintaining production capacity and product quality. Smaller producers often experience longer permitting processes, higher compliance costs, and additional engineering requirements that delay production expansion and infrastructure modernization. Successfully balancing sustainable manufacturing practices with cost efficiency remains a key challenge for companies operating within the global polyacrylic acid industry.

Why is demand increasing for the Polyacrylic Acid (CAS 9003-01-4) Industry?

Demand for the Polyacrylic Acid (CAS 9003-01-4) Industry is increasing because of the rapid expansion of the personal care, cosmetics, pharmaceutical, and industrial manufacturing sectors. More than 68% of skincare and topical pharmaceutical formulations rely on acrylic-based rheology modifiers to improve viscosity, stability, suspension, and texture, while approximately 57% of global polyacrylic acid consumption originates from personal care and cosmetic applications. Pharmaceutical demand continues to rise as more than 48,000 topical pharmaceutical products worldwide utilize acrylic polymer excipients for controlled drug delivery, viscosity stabilization, and active ingredient suspension. During 2025, pharmaceutical-grade carbomer demand increased by approximately 16%, driven by expanding dermatology, wound care, oral care, and controlled-release formulations. Rising consumer demand for premium skincare products, increasing production of topical medicines, expansion of generic drug manufacturing, and growing emphasis on high-performance cosmetic formulations continue to strengthen market demand. Additionally, increasing adoption of environmentally friendly and biocompatible polymer systems, together with expanding pharmaceutical manufacturing in Asia-Pacific and North America, is creating sustained opportunities for the industry.

Segmentation Analysis

The Polyacrylic Acid (CAS 9003014) Market is segmented by product type and application according to polymer functionality, viscosity performance, formulation requirements, and end-use industry demand. Carbomer 940 and Carbomer 980 remain the most widely utilized product grades because of their excellent thickening efficiency, suspension capability, rheological control, and compatibility with pharmaceutical and cosmetic formulations. Together these grades account for approximately 48% of total market consumption, supported by increasing demand for premium skincare products, topical medications, personal hygiene products, and advanced pharmaceutical formulations requiring high-performance polymer excipients.

Application demand is dominated by personal care, cosmetics, pharmaceuticals, and specialty healthcare formulations where polyacrylic acid serves as a critical ingredient for viscosity stabilization, moisture retention, controlled release, and product consistency. Personal care and cosmetics remain the largest application segment with approximately 57% of total market utilization due to continuous expansion of skincare, haircare, oral care, and beauty product manufacturing worldwide. Pharmaceutical applications continue demonstrating strong growth as manufacturers increasingly incorporate pharmaceutical-grade carbomers into dermatological products, topical therapies, controlled-release formulations, and advanced healthcare preparations.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

PAA Carbomer 940

PAA Carbomer 940 remains one of the most widely used polyacrylic acid grades because of its exceptional thickening performance, high viscosity characteristics, excellent clarity, and superior suspension capability within pharmaceutical and cosmetic formulations. Approximately 26% of global carbomer consumption during 2025 consisted of Carbomer 940 as manufacturers increasingly utilized the material in transparent gels, facial creams, medicated formulations, personal care products, and premium skincare applications requiring stable rheological performance. Its excellent compatibility with active ingredients and ability to produce smooth, visually appealing formulations continue supporting widespread industrial adoption.

Manufacturers continue expanding utilization of Carbomer 940 through development of advanced cosmetic formulations, dermatological therapies, oral care products, and pharmaceutical gels requiring reliable viscosity control and long-term formulation stability. Continuous innovation in premium skincare products, pharmaceutical excipients, and personal hygiene applications continues reinforcing the commercial importance of Carbomer 940 across multiple consumer and healthcare industries.

PAA Carbomer 980

PAA Carbomer 980 continues gaining widespread acceptance because of its excellent stability in hydroalcoholic formulations, strong suspension performance, and compatibility with pharmaceutical and sanitizing products requiring consistent rheological properties. Approximately 22% of total market demand during 2025 originated from Carbomer 980 as manufacturers increasingly incorporated this grade into alcohol-based gels, pharmaceutical formulations, sanitizing products, and specialty healthcare applications requiring superior performance under varying formulation conditions. The material provides excellent viscosity stability while supporting effective dispersion of active pharmaceutical ingredients and cosmetic additives.

Growing pharmaceutical manufacturing, increasing demand for sanitizing formulations, expansion of healthcare infrastructure, and rising production of premium personal care products continue supporting broader adoption of Carbomer 980 worldwide. Manufacturers continue investing in production expansion, quality improvement, and advanced formulation development to address growing customer demand across regulated pharmaceutical and cosmetic markets.

By Application

Personal Care and Cosmetics

Personal care and cosmetics remain the largest application segment because polyacrylic acid provides outstanding thickening, stabilizing, suspending, and moisture-retention properties essential for premium skincare and beauty formulations. Approximately 57% of total market demand during 2025 originated from personal care and cosmetic applications as manufacturers increasingly incorporated carbomer materials into facial creams, moisturizing gels, sunscreens, shampoos, styling products, oral care formulations, and advanced skincare solutions. Continuous innovation in premium cosmetics and increasing consumer demand for high-performance beauty products continue strengthening market expansion.

Manufacturers continue developing multifunctional formulations that combine enhanced sensory performance, long-lasting stability, improved texture, and superior product aesthetics through advanced carbomer technologies. Expansion of global beauty markets, rising disposable income, and increasing preference for sophisticated personal care products continue supporting sustained long-term demand for polyacrylic acid within cosmetic manufacturing.

Pharmaceutical

Pharmaceutical applications continue expanding rapidly because polyacrylic acid serves as an essential excipient for topical medications, dermatological products, oral care preparations, ophthalmic formulations, and controlled-release drug delivery systems. Approximately 28% of total market utilization during 2025 originated from pharmaceutical applications as manufacturers increasingly adopted pharmaceutical-grade carbomers to improve formulation stability, viscosity control, active ingredient suspension, and therapeutic performance. Growing demand for topical healthcare products and expanding pharmaceutical production continue driving increased consumption of high-purity acrylic polymer excipients.

Manufacturers continue investing in advanced pharmaceutical formulation technologies, sterile manufacturing processes, and high-purity production systems designed to satisfy stringent regulatory requirements while supporting innovative drug development. Continuous expansion of healthcare infrastructure, biologics manufacturing, and personalized medicine continues creating favorable long-term opportunities for pharmaceutical-grade polyacrylic acid across global healthcare markets.

Which Segment is Growing Faster in the Polyacrylic Acid (CAS 9003-01-4) Market?

The Personal Care and Cosmetics segment is growing faster in the Polyacrylic Acid (CAS 9003-01-4) Market due to the widespread use of carbomer-based polymers in skincare, haircare, oral care, and cosmetic formulations. This segment accounts for approximately 57% of total market consumption, making it the dominant and fastest-growing application area. More than 68% of moisturizing gels, facial creams, lotions, and hair styling products utilize carbomer-based thickening agents because of their superior viscosity control, suspension capability, texture enhancement, and formulation stability. During 2025, cosmetic product launches containing acrylic polymers increased by approximately 18%, while more than 62% of premium skincare products incorporated carbomer-based rheology modifiers to improve shelf life and product consistency. Asia-Pacific alone represents nearly 46% of cosmetic-related polymer demand due to strong skincare manufacturing growth across China, Japan, and South Korea. Continuous innovation in premium beauty products, clean-label cosmetics, sulfate-free formulations, and dermatological skincare is expected to further accelerate growth of the personal care and cosmetics segment.

Polyacrylic Acid (CAS 9003014) Market Regional Outlook

The Polyacrylic Acid (CAS 9003014) Market demonstrates strong regional diversification driven by pharmaceutical manufacturing, cosmetic production, chemical processing, healthcare expansion, and industrial development across major global economies. Asia-Pacific remains the dominant regional market with approximately 44% of worldwide consumption because of its extensive pharmaceutical manufacturing capacity, strong cosmetics industry, and large-scale chemical production infrastructure. North America and Europe continue maintaining substantial demand through advanced pharmaceutical research, premium cosmetic manufacturing, and stringent quality standards supporting production of high-performance polymer materials.

Regional market growth is further supported by increasing investment in healthcare manufacturing, biotechnology research, personal care innovation, and environmentally sustainable polymer production technologies. Manufacturers continue strengthening regional production capabilities, expanding supply networks, and investing in high-purity carbomer manufacturing to satisfy growing demand from pharmaceutical, cosmetic, and industrial customers. Continuous expansion of healthcare and beauty industries is expected to sustain long-term regional market growth.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America remains a major regional market because of its advanced pharmaceutical manufacturing capabilities, mature personal care industry, and strong demand for premium cosmetic ingredients. Approximately 24% of global market demand during 2025 originated from North America as pharmaceutical companies, cosmetic manufacturers, and healthcare producers increasingly utilized high-purity carbomer materials within topical medications, skincare products, and advanced healthcare formulations. Strong regulatory standards and continuous investment in product innovation continue supporting regional market stability.

Manufacturers continue expanding production capabilities while improving polymer quality, formulation performance, and sustainable manufacturing practices to satisfy evolving pharmaceutical and cosmetic industry requirements. Continuous investment in biotechnology research, dermatological product development, and premium personal care formulations continues reinforcing North America's importance within the global polyacrylic acid market.

Europe

Europe continues maintaining a strong market position because of its highly developed cosmetic manufacturing industry, advanced pharmaceutical research, and strict product quality regulations governing healthcare and beauty products. Approximately 22% of global demand during 2025 originated from Europe as manufacturers increasingly adopted premium carbomer materials supporting sophisticated skincare formulations, pharmaceutical excipients, and controlled-release drug delivery systems. Strong emphasis on product quality, sustainability, and environmentally responsible manufacturing continues driving regional market expansion.

Manufacturers continue investing in innovative polymer technologies, environmentally friendly production processes, and advanced formulation capabilities that improve product performance while meeting evolving European regulatory standards. Continuous growth of premium cosmetics, dermatological healthcare products, and pharmaceutical innovation supports sustained regional demand.

AsiaPacific

Asia-Pacific remains the largest regional market because of its extensive pharmaceutical manufacturing base, rapidly expanding cosmetics industry, and strong chemical production infrastructure supporting global supply chains. Approximately 44% of worldwide market demand during 2025 originated from Asia-Pacific as China, India, Japan, South Korea, and other regional economies expanded production of pharmaceuticals, cosmetics, and specialty chemical products requiring advanced carbomer materials. Strong manufacturing capabilities and increasing domestic consumption continue supporting robust regional growth.

Manufacturers continue investing in production expansion, advanced polymer technologies, sustainable manufacturing systems, and export capabilities while strengthening regional supply chains. Rising consumer demand for skincare products, expanding pharmaceutical manufacturing, and continuous healthcare investment continue reinforcing Asia-Pacific's leadership within the global Polyacrylic Acid (CAS 9003014) Market.

Middle East & Africa

The Middle East and Africa region continues experiencing gradual market expansion as pharmaceutical imports, cosmetic manufacturing, industrial processing, and healthcare infrastructure continue developing across the region. Approximately 10% of global market demand during 2025 originated from the Middle East and Africa as manufacturers increasingly adopted carbomer materials for personal care products, pharmaceutical formulations, and industrial applications. Rising urbanization, increasing consumer spending, and expanding healthcare services continue supporting steady market growth.

Manufacturers continue strengthening regional distribution networks, improving product availability, and expanding partnerships with pharmaceutical and cosmetic producers to address growing regional demand. Continued investment in domestic manufacturing, healthcare modernization, and consumer goods production is expected to support sustained long-term growth throughout the Middle East and Africa.

Which Region Dominates the Polyacrylic Acid (CAS 9003-01-4) Industry?

Asia-Pacific dominates the Polyacrylic Acid (CAS 9003-01-4) Industry, accounting for approximately 44% of the global market due to its extensive cosmetic manufacturing, pharmaceutical production, and chemical processing infrastructure. China alone contributes nearly 36% of global production capacity and remains the world's leading exporter of carbomer materials, while India, Japan, and South Korea collectively account for nearly 29% of regional demand. More than 52% of global cosmetics manufacturing output is concentrated in Asia-Pacific, creating substantial demand for Carbomer 940, Carbomer 980, and other specialty acrylic polymers used in skincare, haircare, and pharmaceutical formulations. The region also benefits from expanding generic drug manufacturing, rising pharmaceutical excipient production, competitive manufacturing costs, and increasing investments in specialty polymer facilities. Continuous capacity expansions, government support for chemical manufacturing, rapid industrialization, and growing demand for high-purity pharmaceutical-grade polymers continue to reinforce Asia-Pacific's leadership as the largest regional market for Polyacrylic Acid (CAS 9003-01-4) worldwide.

List of Top Polyacrylic Acid (CAS 9003014) Companies

• SNF Floerger
• Newman Fine Chemical
• Evonik
• Sumitomo Seika
• Corel
• DX Chemical
• Maruti Chemicals
• Ashland
• BASF

List of Top tow Companies Market Share

• Lubrizol: Lubrizol accounts for approximately 19% of global Polyacrylic Acid (CAS 9003014) market share, supported by advanced pharmaceuticalgrade carbomer production and distribution operations across more than 40 countries.

• Tinci Materials: Tinci Materials controls nearly 14% of global market share and operates largescale carbomer production facilities supplying cosmetic and pharmaceutical manufacturers across AsiaPacific, Europe, and North America.

Investment Analysis and Opportunities

Investment activity in the Polyacrylic Acid (CAS 9003014) market increased significantly during 2025 due to rising pharmaceutical and cosmetic manufacturing demand. More than 31% of major chemical producers announced capacity expansion projects focused on pharmaceuticalgrade carbomer production. AsiaPacific attracted approximately 47% of global specialty polymer investments because of lower manufacturing costs and growing export activity.

China and India collectively added over 210,000 metric tons of acrylic polymer production capacity during 2024 and 2025. More than 26 new cosmetic ingredient manufacturing facilities were established globally to support premium skincare product demand. Pharmaceutical excipient investments also accelerated, with 22% of polymer research budgets directed toward controlledrelease and ophthalmic applications.North American manufacturers invested heavily in AIbased quality control systems, improving viscosity consistency by 21%. 

New Product Development

New product development activity in the Polyacrylic Acid (CAS 9003014) market intensified during 2025 as manufacturers focused on pharmaceuticalgrade purity, lowirritation formulations, and sustainable polymer technologies. More than 43% of new carbomer launches targeted premium skincare and topical pharmaceutical applications.

Manufacturers introduced advanced transparent gel polymers with improved electrolyte tolerance and faster dispersion capabilities. More than 28% of newly developed carbomer grades were specifically designed for sulfatefree and alcoholbased formulations. Pharmaceutical companies expanded research into controlledrelease drug systems utilizing ultrapure acrylic polymers with residual solvent levels below 0.5%.AsiaPacific manufacturers launched over 70 specialty carbomer formulations during 2025, primarily targeting Kbeauty and dermatological applications.

Five Recent Developments (20232025)

• Lubrizol expanded pharmaceuticalgrade carbomer production capacity by 18% during 2025 to support increasing demand for topical drug delivery formulations.

• Tinci Materials increased annual carbomer output by 22% in 2024 through the addition of automated polymerization systems and advanced purification technology.

• BASF implemented wastewater recycling systems across multiple acrylic polymer facilities in 2025, reducing industrial water consumption by 27%.

• Evonik introduced new lowirritation carbomer formulations in 2024 designed for sulfatefree skincare products, improving compatibility performance by 16%.

• Ashland launched advanced transparent gel carbomer technologies in 2025, enhancing viscosity stability by 19% in hydroalcoholic cosmetic formulations.

Report Coverage of Polyacrylic Acid (CAS 9003014) Market

The Polyacrylic Acid (CAS 9003014) market report provides extensive analysis of production trends, application demand, regional manufacturing activity, technological innovation, and competitive developments across global markets. The report evaluates more than 11 major manufacturers and examines production operations across over 27 countries.

Coverage includes detailed segmentation by carbomer type, including Carbomer 940, Carbomer 980, Carbomer 676, Carbomer U20, Carbomer U21, and Carbomer SF1. Application analysis focuses on personal care, cosmetics, pharmaceutical formulations, oral care, and industrial processing sectors. More than 57% of market utilization originates from cosmetic applications, while pharmaceutical demand contributes approximately 28%.Regional evaluation includes North America, Europe, AsiaPacific, and Middle East & Africa, covering production capacity, importexport activity, regulatory compliance, and technological investments.

Polyacrylic Acid (CAS 9003-01-4) Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1083.49 Million in 2026
Market Size Value By	USD 2081.88 Million by 2035
Growth Rate	CAGR of 7.53% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : PAA Carbomer 940 PAA Carbomer 980 PAA Carbomer 676 PAA Carbomer U20 PAA Carbomer U21 PAA Carbomer SF-1 By Application : Personal Care and Cosmetics Pharmaceutical
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample